Access user guides, primary care practice manuals, and procedural instructions related to cervical screening and human papillomavirus (HPV) testing guidelines.
Cervical screening is a vital public health initiative designed to prevent cervical cancer by detecting human papillomavirus (HPV) and abnormal cell changes early. This section provides comprehensive user guides, primary care good practice manuals, and informational resources intended for both healthcare professionals and patients.
These resources include guidelines on screening intervals, eligibility criteria, the call and recall systems, and best practices for supporting informed participation across various healthcare frameworks. The provided documents aim to equip primary care staff with the necessary information to address patient barriers, communicate the benefits and harms of screening, and reduce inequalities in public health uptake.
Uusimmat käyttöohjeet manuals+ tälle tuotemerkille kuratoitu.
Yleisiä kysymyksiä tämän tuotemerkin käyttöoppaista, rekisteröinnistä ja tuesta.
The screening frequency varies based on age and HPV status. Generally, people aged 25-49 are invited every three to five years depending on the regional health guidelines, while those aged 50-64 are invited every five years.
The middle of the menstrual cycle is the optimal time to obtain a good sample. Vältä ottamaan sampvähemmän kuukautisten aikana, jos mahdollista, mutta se voidaan tehdä tarvittaessa.
A healthcare professional will take a sampkohdunkaulasta peräisin olevia soluja, jotka testataan ihmisen papilloomaviruksen (HPV) varalta. Jos positiivinen, sample is examined further for changes in the cervical cells.
Yes, anyone with a cervix aged 25–64 is eligible for screening. If registered as male or 'indeterminate' at a GP practice, they may not receive automatic invitations and will need to request a screening through their GP.